Literature DB >> 9599660

Comparative protection against oxyradicals by three flavonoids on cultured endothelial cells.

L H Zeng1, J Wu, B Fung, J H Tong, D Mickle, T W Wu.   

Abstract

Oxygen-derived free radicals are known to injure the endothelium of aorta in diverse disorders. In this study we compared the cytoprotective effects of three flavonoids against oxyradical damage to porcine aortic endothelial cells in vitro. Cultured porcine aortic endothelial cells were exposed to oxyradicals generated by xanthine oxidase--hypoxanthine (XO-HP). The cytoprotective activities of morin, quercetin, and catechin on these systems were compared using established morphologic criteria. The results in the XO-HP system showed that morin at 0.125, 0.25, and 0.5 mM delayed cell necrosis to 27.4 +/- 1.3, 46.8 +/- 1.8, and longer than 70 min, respectively, compared with 12.0 +/- 1.3 min in the control group. These degrees of protection were significantly stronger than those provided by quercetin and catechin at corresponding concentrations (p < 0.01). Morin and quercetin were moderate inhibitors of xanthine oxidase on the basis of the oxygen consumption rate, whereas catechin at the same concentrations had little inhibitory effect. The data from uric acid formation and cytochrome c reduction were consistent with the oxygen consumption measurement for the three flavonoids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9599660     DOI: 10.1139/o97-062

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  2 in total

1.  Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.

Authors:  Zhen-tao Zhang; Xue-bing Cao; Nian Xiong; Hong-cai Wang; Jin-sha Huang; Sheng-gang Sun; Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

2.  Flavonol and flavone intake and the risk of intermittent claudication in male smokers.

Authors:  Tero Hirvonen; Markareetta E Törnwall; Pirjo Pietinen; Pasi Korhonen; Demetrius Albanes; Jarmo Virtamo
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.